1-nitrohydroxyphenyl-n-benzoylalanine has been researched along with trihexyphenidyl in 1 studies
| Studies (1-nitrohydroxyphenyl-n-benzoylalanine) | Trials (1-nitrohydroxyphenyl-n-benzoylalanine) | Recent Studies (post-2010) (1-nitrohydroxyphenyl-n-benzoylalanine) | Studies (trihexyphenidyl) | Trials (trihexyphenidyl) | Recent Studies (post-2010) (trihexyphenidyl) |
|---|---|---|---|---|---|
| 42 | 0 | 36 | 950 | 84 | 93 |
| Protein | Taxonomy | 1-nitrohydroxyphenyl-n-benzoylalanine (IC50) | trihexyphenidyl (IC50) |
|---|---|---|---|
| Muscarinic acetylcholine receptor M2 | Homo sapiens (human) | 0.034 | |
| Muscarinic acetylcholine receptor M4 | Homo sapiens (human) | 0.0055 | |
| Muscarinic acetylcholine receptor M5 | Homo sapiens (human) | 0.012 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 2.4498 | |
| Muscarinic acetylcholine receptor M1 | Homo sapiens (human) | 0.0056 | |
| Muscarinic acetylcholine receptor M3 | Homo sapiens (human) | 0.015 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.108 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bhatia, KP; Burke, D; Carecchio, M; Chandrashekar, HS; Edwards, MJ; Footitt, EJ; Kojovic, M; Lachmann, RH; Murphy, E; Parees, I; Rubio-Agusti, I | 1 |
1 other study(ies) available for 1-nitrohydroxyphenyl-n-benzoylalanine and trihexyphenidyl
| Article | Year |
|---|---|
Movement disorders in adult patients with classical galactosemia.
Topics: Adult; Anti-Dyskinesia Agents; Benzamides; Botulinum Toxins; Brain; Cross-Sectional Studies; Databases, Factual; Female; Galactosemias; Humans; Magnetic Resonance Imaging; Male; Movement Disorders; Muscarinic Antagonists; Retrospective Studies; Severity of Illness Index; Trihexyphenidyl; Tyrosine; Young Adult | 2013 |